We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$37.2M +$974K +14,357 +2%
AIM
2
ARK Investment Management
Florida
$35M +$5.57M +82,159 +16%
NAMA
3
Nikko Asset Management Americas
New York
$29.2M -$335K -4,945 -1%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$29.2M -$335K -4,945 -1%
AVM
5
Arch Venture Management
Illinois
$18.2M -$1.7M -25,000 -8%
FP
6
Flagship Pioneering
Massachusetts
$17.4M
BlackRock
7
BlackRock
New York
$16.7M -$322K -4,746 -2%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$13.5M +$15.4M +227,500 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$10.7M +$8.62K +127 +0.1%
SB
10
Samsara BioCapital
California
$9.6M
DM
11
Deerfield Management
New York
$7.53M
JP Morgan Chase
12
JP Morgan Chase
New York
$5.23M -$438K -6,455 -7%
BBA
13
Baker Bros. Advisors
New York
$4.09M
State Street
14
State Street
Massachusetts
$3.87M -$202K -2,983 -4%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$3.34M +$422K +6,224 +12%
PCM
16
Portolan Capital Management
Massachusetts
$3.04M +$1.26M +18,572 +57%
AG
17
Artal Group
Luxembourg
$3M +$3.43M +50,614 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.95M +$154K +2,264 +5%
SCM
19
Sio Capital Management
New York
$2.78M +$136K +2,000 +4%
Northern Trust
20
Northern Trust
Illinois
$2.42M +$39.6K +584 +1%
RG
21
Redmile Group
California
$1.26M
Charles Schwab
22
Charles Schwab
California
$1.22M -$1.22K -18 -0.1%
Nuveen
23
Nuveen
North Carolina
$822K -$13.6K -200 -1%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$692K +$36.6K +540 +5%
Invesco
25
Invesco
Georgia
$534K +$611K +9,001 New